View Curriculum Vitae.doc

910 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
910
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

View Curriculum Vitae.doc

  1. 1. CURRICULUM VITAE ROBERT W. PETERS Professor of Medicine Division of Cardiology Department of Medicine University of Maryland Chief, Cardiology Section Baltimore VA Medical Center Baltimore, Maryland 21201 Office Location – 4D129A, VA Medical Center Phone: # 410 605 7191 Fax: # 410 605 7934 E-mail: robert.peters2@va.gov EDUCATION and TRAINING: 1959 - 1963 Columbia University, New York City: B.A. 1963 - 1967 Chicago Medical School, Chicago, IL: M.D. 1967 - 1968 University of Southern California, Los Angeles County General Hospital (Internship), Los Angeles, CA 1968 - 1969 Michael Reese Hospital (Residency), Chicago, IL 1971 - 1972 George Washington University Hospital (Residency), Washington, DC 1972 - 1974 University of California San Francisco, Mount Zion Hospital (Cardiology Fellowship) San Francisco, CA CERTIFICATION: 1973 American Board of Internal Medicine 1975 American Board of Internal Medicine Cardiovascular Subspecialty Exam LICENSURE: California (inactive); Maryland MILITARY SERVICE:
  2. 2. 1969 - 1970 U.S. Army Medical Corps Viet Nam 1970 - 1971 Walter Reed Army Hospital FACULTY POSITIONS: 1992 Professor of Medicine, University of Maryland School of Medicine 1988 - Present Chief, Cardiology Section Baltimore VA Medical Center 1979 - 1992 Associate Professor of Medicine, University of Maryland School of Medicine 1992 - Present Professor of Medicine, University of Maryland School of Medicine 1979 - 1995 Director, Coronary Care Unit, Baltimore VA Medical Center 1977 - 1979 Assistant Professor of Medicine in Residence, University of California, San Francisco, Division of Cardiology 1976 - 1979 Director, Coronary Care Unit, San Francisco General Hospital 1975 - 1976 Acting Director, Coronary Care Unit, San Francisco General Hospital 1974 - 1975 Program Project Officer, National Medical Association Audiovisual Grant for Production of Self-Instructional Packets on Acute Myocardial Infarction 1974 - 1976 Instructor of Medicine, University of California, San Francisco Division of California COMMITTEES: 1972 - 1974 Pharmacy and Therapeutics Committee Mt. Zion Hospital 1975 - 1979 Critical Care Committee San Francisco General Hospital 1975 - 1979 CCU Discharge Planning Committee San Francisco General Hospital 1977 - 1979 Research Committee San Francisco General Hospital
  3. 3. 1979 - 1983 Mortality Classification Committee Beta Blocker Heart Attack Trial (NHBLI) 1979 - 1981 Chairperson, CPR Committee Baltimore VA Medical Center 1981 - 1993 Chairperson, Critical Care Committee Baltimore VA Medical Center 1985 - Present Chairperson, Human Research Subcommittee Baltimore VA Medical Center 1981 - 1994 CCU Committee Baltimore VA Medical Center 1987 - 1994 Publications and Ancillary Studies Committee, Cardiac Arrhythmia Suppression Trial (CAST) 1979 - 1981 Chairperson, CPR Committee Baltimore VA Medical Center 1983 - 1986 Research and Development Committee Baltimore VA Medical Center 1983 - 1991 Pharmacy and Therapeutics Committee Baltimore VA Medical Center 1985 - 1990 Smoking Committee Baltimore VA Medical Center 1980 - 1992 Human Volunteers Research Committee University of Maryland School of Medicine (Institutional Review Board) 1986 - 1989 Research Committee, Maryland Affiliate of American Heart Association 1987 - Present Member, VA Cardiology Field Advisory Group (National) 1993 - 1995 Member, Intravenous Cordarone Mortality Committee (Wyeth-Ayerst Research) 1998 - 1999 Member, Clinical Endpoints Adjudication Committee ELITE II Trial (Merck) 2001-present Member, Advisory Group for the Centers for Medicare and Medicare Services (CMS) 2002-present Cardiology Consultant, Geriatric Research Educational Clinical
  4. 4. Center, Department of Gerontology, University of Maryland 2004-present Member, Advisory Committee, The Claude D Pepper Center, Geriatric Research Educational Clinical Center, University of Maryland 2007-present Member, Circulatory System Devices Advisory Panel, U. S. Food and Drug Administration TEACHING RESPONSIBILITIES Cardiology Blue Team Attending - VA Medical Center 4 months Electrophysiology Service Attending - VA Medical Center 52 weeks HONORS and AWARDS: 1965 Pharmacology Research Prize Chicago Medical School 1970 Bronze Star U.S. Army Medical Corps 1981 Honorary Alpha Omega Alpha Society Chicago Medical School 1982 Visiting Professor of Medicine Mt. Zion Hospital and Medical Center San Francisco, California CONTRACTS and GRANTS 1979 Principal Investigator, Beta Blocker Heart Attack Trial (NHLBI) 1979 Regional Advisory Groups (RAGS) VA 1981 Coinvestigator, Persantine and Aspirin Reinfarction Study (Part II) 1986 Principal Investigator, Cardiac Arrhythmia Suppression Trial (NHLBI) 1989 Principal Investigator, Recainam Arrhythmia Suppression Trial (Wyeth- Ayerst Research) 1998 Principal Investigator, The Prophylaxis of Medical Patients for Thromboembolism (PROMPT) Pilot Study (VA Cooperative Study) 2002 Principal Investigator, Triggers of Ventricular Arrhythmias (TOVA) NHLBI 2002 Principal Investigator, A Simplified System for Internal Cardioversion of Atrial Fibrillation
  5. 5. PRESENTATIONS: 1. Cooperative prospective study of bundle branch block.. American Heart Association meetings, November, 1975. Anaheim, California. 2. Clinical implications of prospective studies of bundle branch block. Recent Advances in Internal Medicine. University of California, San Francisco, California. April, 1976. 3. Panel on antiarrhythmic drugs. Recent Advances in Internal Medicine. University of California, San Francisco, California. April, 1976. 4. Clinical applications of intracardiac electrogram. Academy for the Advancement of Medical Instrumentation meeting. San Francisco, California. March, 1977. 5. Management of patients with AV or bundle branch block. American Medical Association meetings. San Francisco, California. June, 1977. 6. Prophylactic permanent pacemakers for patients with chronic bundle branch block. American College of Cardiology. Anaheim, California. March 6-9, 1978. 7. The pre-hospital phase of acute myocardial infarction. American College of Physicians. San Francisco, California. March, 1979. 8. Serial studies of infranodal conduction in patients with bundle branch block. American Heart Association meetings. Dallas, Texas. November, 1978. 9. Site and pattern of progressive atrioventricular block in patients with bundle branch block: A long-term collaborative study. American Heart Association meetings. Anaheim, California. November, 1979. 10. Serial electrophysiologic studies in patients with bundle branch block. American Heart Association Meetings. Dallas, Texas. November, 1981. 11. Graded influence of the H-V interval on the incidence of spontaneous infranodal block. American Heart Association Meetings. Dallas, Texas. November, 1981 12. Effects of acute changes in ventricular volume and pressure of AV conduction. American College of Cardiology Meetings. Atlanta, Georgia. April, 1982. 13. Permanent prophylactic cardiac pacing for patients with bundle branch block and syncope. American Heart Association Meetings. Dallas, Texas. November, 1982. 14. Electrophysiologic evaluation of patients with bundle branch block. American Heart Association Meetings. Dallas, Texas. November, 1982. 15. Electrophysiologic effects of cigarette smoking in man. American Heart Association
  6. 6. Annual Scientific Session. Anaheim, California. November, 1983. 16. Longterm Management of paroxysmal tachycardia by burst overdrive pacing. American College of Cardiology Meetings. Dallas, Texas. March, 1984. 17. Prognostic value of QTC prolongation: The BHAT experience. American Heart Association Annual Scientific Session. Miami Beach, Florida. November 1984. 18. Propranolol and the circadian variation in frequency of sudden cardiac death: The BHAT Experience. American Heart Association Annual Scientific Session. Anaheim, California, 1987. 19. Circadian Variation in sudden cardiac death in the Beta Blocker Heart Attack Trial, International Council on Circadian Variation, Boston, Massachusetts, Feb 1988. 20. Circadian Pattern of sudden arrhythmic death in the Cardiac Arrhythmia Suppression Trial, International Council on Circadian Variation, Palm Beach, Florida., May, 1990. 21. Circadian Variation of sudden arrhythmic death in patients receiving encainide or flecainide in the Cardiac Arrhythmia Suppression Trial. American Heart Association Annual Scientific Session, Dallas, Texas, November 1990. 22. Relationship of onset of acute myocardial infarction to time of awakening: The CAST experience, International Council on Circadian Variation, Key Largo, Florida, April 1991. 23. Overdrive Atrial Pacing for Management of Atrial Flutter World Congress of Cardiology/North American Society for Pacing and Electrophysiology Washington, D.C., May, 1991. 24. Relationship of onset of acute myocardial infarction to the time of awakening: The CAST Experience. American Heart Association Annual Scientific Session, Anaheim, California 1991. 25. Treatment of ventricular arrhythmias in the 1990's. 10th Annual Advances in Cardiology. San Francisco, California December 1992. 26. Uses and limitations of the implantable defibrillator. 10th Annual Advances in Cardiology. San Francisco, California December 1992. 27. Increased onset of acute myocardial infarction on Monday. American Heart Association Annual Scientific Session Atlanta, Georgia. November 1993. 28. Smoking Cessation and arrhythmic death. American Heart Association. Annual Scientific Session. Atlanta, Georgia, November, 1993.
  7. 7. 29. Morning Peak in ventricular arrhythmias detected by time of implantable defibrillator therapy. American College of Cardiology Annual Scientific Sesssion; New Orleans, Louisiana, March 1995. 30. Seasonal variation in implantable cardioverter defibrillator therapy. American College of Cardiology Annual scientific Session; Anaheim, CA, March 2000.
  8. 8. INVITED ARTICLES: 1. Hirschfeld D, Peters RW, Abbott JA, Kunkle F, and Scheinman MM: The sick sinus and ailing atrium. Western Journal of Medicine, 12:473, December, 1974. 2. Peters RW: Differential diagnosis of chest pain. Emergency Medical Service 4:33, November-December, 1975. 3. Hart R, Peters RW, Rubinstein M, O'Young J, Thomas A and Scheinman MM: A review of instrumentation and therapeutic techniques in the diagnosis and management of patients with supraventricular tachycardia. Medical Instrumentation 12:268-273, 1978. 4. Peters RW, Scheinman MM: Emergency management of supraventricular tachycardia. Medical Clinics of North America 63:73-92, 1979. 5. Scheinman MM, Goldschlager N, Peters RW: Bundle branch block. Cardiovascular clinics 11:57-81, 1980. 6. Peters RW: Treatment of supraventricular tachycardia. Recenti Progressi on Medicina 71:48-68, 1981. 7. Peters RW: Emergency: Paroxysmal supraventricular tachycardia. Hospital Medicine 18(4):68c-68o, 1982. 8. Somelofski C and Peters RW: Antiarrhythmic drugs: The issue of compliance. Annals of the N.Y. Academy of Sciences 432:286-295, 1984. 9. Peters RW: Permanent cardiac pacing for complete heart block complicating acute anterior myocardial infarction. Proceedings in International Symposium on Progress in Clinical Pacing 1984. 10. Peters RW: Temporary transcutaneous pacing: New indications for an old technique. Journal of the Association of Operating Room Nurses 44:245-249, 1986. 11. Peters RW: Beta blockers and mortality following myocardial infarction: More questions than answers (editorial). Archives Internal Medicine 147:33, 1987. 12. Peters RW: Indication for pacing in acute myocardial infarction. Cardio 4:59, 1987. 13. Peters RW: Arrhythmias and chest pain. Chest pain and Cardiovascular Diagnosis 3:1987. 14. Peters RW, Fisher ML: Combined use of procainamide and beta blockers in the management of ventricular arrhythmias. Arrhythmia Clinics 4:10, 1987. 15. Tomasseli G, Peters RW, Guarnieri T: The automatic implantable cardioverter
  9. 9. defibrillator in clinical practice. Is it effective and when should it be used? Choices in Cardiology. 2:121, 1988. 16. Peters RW: Propranolol and the morning increase in sudden cardiac death (the BHAT Experience) American Journal of Cardiology 66:57-59, 1990. 17. Peters RW: Circadian rhythms and sudden cardiac death: Pathophysiologic insight gained from clinical trials. Current Concepts in Arrhythmia Management (Summer: 9-16, 1991). 18. Peters, RW, Gold MR: Arrhythmias developing after coronary artery bypass surgery. Cardio. Nov. 1992:31-40. 19. Peters, RW, Fisher ML: Clinical questions: When are ventricular extrasystoles important? Choices in Cardiology 7:237,1993 . 20. Peters, RW, Fisher ML: Clinical questions: Use of amiodarone. Choices in Cardiology 8:57-60, 1994 21. Peters,RW: Circadian incidence of arrhythmias and sudden cardiac death. Cardiovascular circadian rhythms 1994;5:1-8. 22. Peters RW, Brooks MM: Does smoking cessation cause a reduction in arrhythmic death? Cardiology Review 1996;13:11-14. 23. Peters RW: Circadian patterns and triggers of sudden cardiac death. Cardiology Clinics 1996;14:185-194. 24. Peters RW, Mergner W, Ghiorzi T, Benitez RM. A 70 year old man with atrial fibrillation and stroke. Maryland Medical Journal March/April 1999:74-79. 25. Peters RW. Heart block and conduction disturbances. In Current Treatment Options in Cardiovascular Disease (Ed. Francis GS) Current Science Inc. Philadelphia 1999;1:153-165. 26. Gold MR, Peters, RW. Permanent pacemakers in patients with dilated cardiomyopathy. Cardiac Electrophysiology Review 1999;2:381-383.. 27. Peters RW, Gold MR. Pacing for patients with congestive heart failure and dilated cardiomyopathy. Cardiovascular Clinics of North America 2000;18:55-66. 28. Peters RW, Gold MR. Implantable cardioverter defibrillators. Med Clin North Amer 2001;85:343-365. 29. Peters RW, Gold MR. Are there seasonal variations in the incidence of sudden cardiac death and life-threatening arrhythmias? J Critical Illness 2001;16:358-359..
  10. 10. 31. Gold MR Peters RW. How much is the arrhythmic risk for heart failure patients and does resynchronization therapy modify it? Proceedings of the 7th International Workshop on Cardiac Arrhythmias, Venice 2001. 32. Peters RW, Gold MR. The influence of gender on arrhythmias. Cardiol Rev 2004;12:97-105. 33. Peters RW, Gold MR. Editorial: Chronobiology of arrhythmias: interesting curiosity or important clue to pathophysiology? J Cardiovasc Electrophysiol 2002;10:1015-16. 34. Peters RW. Editorial: Obstructive sleep apnea and cardiovascular disease. CHEST 2005;127:1-3 35. Peters RW. How strong is the evidence that the treatment of obstructive sleep apnea syndrome improves outcomes in patients with obstructive sleep apnea? The Journal of Respiratory Diseases 2005;26:283. 36. Peters RW. Clinical Consultation: Reducing cardiovascular risks in patients with obstructive sleep apnea. The Journal of Respiratory Diseases (Supplement) July, 2006:6. 37. Anand RG, Peters RW, Donahue TP. Obesity and dysrhythmias. Journal of Cardiometabolism. (In Press).
  11. 11. REFEREED ARTICLES 1. Scheinman MM, Kunkle F, Peters RW, Hirschfeld D, Schoenfeld P, Abbott JA, Modin G: Atrial pacing in patients with sinus node dysfunction. American Journal on Medicine, 61:641, November, 1976. 2. Peters RW, Rubinstein M, and Scheinman MM: Precise "on-line" measurements of intracardiac electrograms. Journal of Electrocardiography, 9:329, 1976. 3. Peters RW, Scheinman MM: Effects of intravenous carnitive in patients with ventricular arrhythmias. Cardiovascular Medicine, 2:701, 1977. 4. Scheinman MM, Peters RW, Mies C and Modin G: Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation 56:240-245, 1977. 5. Peters RW, Norman A, Parmley W, Emilson B, Scheinman MM, Cheitlin M: Effect of methylprednisone on myocardial infarct size in man. Chest 73:483-488, 1978. 6. Peters RW, Shafton E, Frank S, Thomas A, and Scheinman MM: Uses and limitations of radio frequency-triggered pacemakers. A long-term follow-up study. Annals of Internal Medicine, 88:17-22, 1978. 7. Scheinman MM, Strauss HC, Abbott J, Peters, RW, Benditt DG, Evans GT, Wallace AG: Clinical and electrophysiologic evaluation of patients with sinus pauses and exit block. European Journal of Cardiology 8:41-60, 1978. 8. Massie B, Scheinman MM, Peters RW, Desai JM, Hirschfeld D, O'Young J: Clinical and electrophysiologic findings on patients with paroxysmal slowing of the sinus rate and apparent Mobitz type II AV block. Circulation 58:305-314, 1978. 9. Desai JM, Scheinman MM, Peters RW, and O'Young J: Electrophysiologic effects of disopyramide in patients with bundle branch block. Circulation 59:215-225, 1979. 10. Peters RW, Scheinman MM, Modin G, O'Young J, Somelofski CA, Mies C.: Permanent prophylactic pacing in patients with chronic bundle branch block. American Journal of Medicine 66:978-985, 1979. 11. Peters RW, Scheinman M, Raskin S, Desai J: Determination of His-Purkinje refractoriness in man by means of His bundle pacing. Circulation 60:956-959. 12. Scheinman MM, Remedios P, Cheitlin M, Peters RW, Holford M, Desai J, Abbott J: Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarction. Circulation 62:20-28, 1980. 13. Peters RW, Scheinman MM, Raskin S, Thomas AN: Unusual complications of
  12. 12. epicardial pacemakers. American Journal of Cardiology 45:1088-1094, 1980 14. Desai J, Scheinman MM, Hirschfeld D, Gonzalez R, Peters RW: Cardiovascular collapse associated with disopyramide therapy. Chest 79:545-551, 1981. 15. Gonzales R, Scheinman MM, Desai J, Kersh E, Peters RW: Enhanced atrioventricular nodal conduction in a patient with dual extranodal pathways. Journal of Electrocardiology 13(1), 85-92, 1980. 16. Peters RW, Scheinman MM, Gonzalez RP: Atrial and ventricular vulnerability in a patient with Wolff-Parkinson-White Syndrome. Pace 4:17-22, 1980. 17. Peters RW, Wohl BA, Fisher ML, Carliner NH, Plotnick GD: Nonoperative removal of a tined-tipped endocardial pacemaker catheter. Pace 5:129-132, 1982. 18. Wohl BA, Peters RW, Carliner NH, Plotnick GD, Fisher ML: Late unheralded pacemaker pocket infection due to staphylococcus epidermidis: A new clinical entity. Pace 5:190-195, 1982. 19. Gonzalez R, Scheinman M, Thomas A, Desai J, Peters RW, Dzinzio B: Electrophysiologic characterization of surgically induced HIS bundle rhythm in man. Pace 5:152-162, 1981. 20. Peters RW, Scheinman MM, Dhingra R, Rosen K, McAnulty J, Rahimtoola S, Modin G: Serial electrophysiologic studies in patients with chronic bundle branch block. Circulation 65:1480-1485, 1982. 21. Scheinman MM, Peters RW, Sauve MJ, Desai J, Abbott JA, Cogan J, Wohl B, William K: The value of the HQ interval in patients with bundle branch block and the role of prophylactic permanent pacing. American Journal of Cardiology 50:1316-1322, 1982. 22. Beta-Blocker Heart Attack Trial Research Group: A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. Journal of the American Medical Association 247:1707, 1982. 23. Plotnick GD, Fisher ML, Lerner B, Carliner NH, Peters RW, Becker L: Collateral circulation in unstable angina. Chest 82:719-725, 1982. 24. Fisher ML, Carliner NH, Becker LC, Peters RW, Plotnick GD: Serum creatine kinase in the diagnosis of acute myocardial infarction: Optimal frequency sampling. JAMA 249:393-394, 1983. 25. Peters RW, Resnick S, Fisher ML, Carliner NH, Plotnick GD, Scheinman MM: Acute changes in infranodal conduction time following left ventriculography and sublingual nitroglycerin administration in man. American Heart Journal 106:464-70,
  13. 13. 1983. 26. Peters RW, Alikhan M, Morady F, Carliner NH, Scheinman MM: Unusual features of bypass conduction in Wolff-Parkinson-White syndrome and atrial fibrillation. American Journal of Cardiology 52:1357-1359, 1983. 27. Peters RW, Hamilton BP, Hamilton J, Kuzbida G, Pavlis R: Mechanism of arrhythmias following abrupt clonidine withdrawal. Clinical Pharmacology and Therapeutics 34:435-439, 1983. 28. Kushner M, Magiros E, Peters RW, Carliner NH, Plotnick GD, Fisher ML: The electrophysiologic effects of oral cibenzoline. Journal of Electrocardiology 17:15-24, 1984. 29. Hall-Craggs M, Light P, Peters RW: Immune complex nephritis developing during treatment with the calcium-blocking agent nifedipine - A case report. Human Pathology 15:691-694, 1984. 30. Scheinman MM, Peters RW, Morady F, Sauve MJ, Malone P, Modin S; Electrophysiologic studies in patients with bundle branch block. Pace 6:1157-1165, 1983. 31. Fisher ML, Kelemen MH, Collins D, Holder L, Winzeberg G, Plotnick GD, Morris F, Moran G, Carliner NH, Peters RW, Strauss HW: Technetium-99m pyrophosphate infarct avid scintigraphy: Limitations in the diagnosis of patients with suspected acute myocardial infarction. American Heart Journal 110:347-353, 1985. 32. Peters RW, Nussbaum S, Mailhot J, Lief LH, Paley HW: Catheter-induced A-V nodal block occurring during electrophysiologic study, Pace 7:248-251, 1984. 33. Peters RW, Scheinman MM, Morady F, Jacobson L: Long-term management of recurrent tachycardia by cardiac burst pacing. Pace 8:35-44, 1985. 34. Peters RW, Kushner M, Knapp K: Giant pacemaker spikes: An electrocardiographic artifact. Chest 87:256-257, 1985. 35. Weber L, Nashel DJ, Peters RW: Persistent chest pain due to sternal wire sutures: A complication of coronary artery bypass surgery. Southern Medical Journal 78:1018-1019, 1985. 36. Morady F, Higgins J, Peters RW, Schwartz AB, Shen EN, Bhandari A, Scheinman MM, Sauve MJ: Electrophysiologic testing on bundle branch block and unexplained syncope. American Journal of Cardiology 54:587-591, 1984. 37. Ochitill HN, Havassy B, Byrd RC, Peters RW: Leaving a cardiology service against medical advice. J. Chronic Dis 38:79-84, 1985.
  14. 14. 38. Carliner NH, Fisher ML, Plotnick GD, Garbart H, Rapport A, Kelemen MH, Moran GW, Gadacz T, Peters RW: Routine preoperative exercise testing in patients undergoing major non-cardiac surgery. American Journal of Cardiology 56:51-58, 1985. 39. Kmetzo, JJ, Peters RW, Plotnick GD, Carliner NH, Baumgartner WA, Fisher ML: Left atrial mass: Thrombus mimicking myxoma. Chest 88:906-907, 1986. 40. Berliner D, Okun M, Peters RW, Carliner NH, Plotnick GD, Fisher ML: Transcutaneous temporary pacing in the operating room. JAMA 254:84-86, 1985. 41. Fisher ML, Plotnick GD, Peters RW, Carliner NH: Beta-blockers in congestive cardiomyopathy: Conceptual advance or contraindication? American Journal of Medicine 80 (suppl 2B):59-66, 1986. 42. Weber L, Peters RW: Delayed chest wall complications of median sternotomy. Southern Medical Journal 79:723-727, 1986. 43. Kushner M, Peters RW: Prolonged sinus arrest complicating a thrombotic stroke. Pace 9:248-249, 1986. 44. Persantine-Aspirin Reinfarction Study Group: Persantine-aspirin reinfarction study part II: Secondary coronary prevention with persantine and aspirin. JACC 7:251-269, 1986. 45. Carliner NH, Fisher ML, Plotnick GD, Moran GW, Kelemen MH, Gadacz TR, Peters RW: The preoperative electrocardiogram as an indicator of risk in major noncardiac surgery. Canadian Journal of Cardiology 2:134-137, 1986. 46. Peters RW, Byington R, Arensberg D, Friedman LM, Romhilt DW, Barker A, Laubach C, Wilmer G, Goldstein S: Mortality in beta blocker heart attack trial: The circumstances surrounding death. J Chronic Dis 40:75-82, 1987. 47. Schamp DJ, Carliner NH, Peters RW: Pindolol therapy for bradycardia/tachycardia syndrome. Canadian Journal of Cardiology 3:212, 1987. 48. Celano C, Peters RW, Fisher ML: Coronary collateral blood flow in a patient with angiographically normal coronary arteries. Catheterization and Cardiovascular Diagnosis 13:325, 1987. 49. Peters RW, Benowitz NL, Valenti S, Modin G, Fisher ML: The electrophysiologic effects of cigarette smoking in patients with and without chronic beta blocker therapy. American Journal of Cardiology 60:1078, 1987. 50. Panos R, Sutton F, Young-Hyman P, Peters RW: Sudden Death Associated with Alcohol Ingestion. Pace 11:1988.
  15. 15. 51. Peters RW, Hamilton B, Hamilton J: The Incidence of Chronic Arrhythmias Associated With Mild Hypocalcemia induced by low-dose diuretic therapy in hypertensive Southern Medical Journal. 82:966, 1989. 52. Peters RW, Muller JE, Goldstein S, Byington R, Friedman L. Propranolol and the Morning Increase in the Frequency of Sudden Cardiac Death (BHAT Study) American Journal of Cardiology. 63:1518, 1989. 53. The Cardiac Arrhythmia-Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal Medicine 1989; 321:406-412. 54. Jafri SM, Tilley BC, Peters RW, Schultz LR, Goldstein S. Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction American Journal of Cardiology. 217:271-276, 1990. 55. Peters RW, Byington RP, Barker A, Yusuf S. Prognostic valve of prolonged ventricular repolarization following myocardial infarction: The BHAT experience. J Clin Epidem 43:167-172, 1990. 56. Peters RW, Propranolol and the morning increase in sudden cardiac death (the BHAT Experience) American Journal of Cardiology 66:57-59, 1990. 57. Echt DS, Liebson PR, Mitchell JB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene L, Hunther M, Richardson D and the CAST Investigators. Mortality and Morbidity in patients randomized to receive encainide, flecainide or placebo in the Cardiac Arrhythmia Suppression Trial. New Eng J Med 324:781-788, 1991. 58. Gillis AM, Peters Rw, Mitchell LB, Duff HJ, McDonald M, Wyse DG. Effects of left ventricular dysfunction on the circadian variation of ventricular premature depolarization. American Journal of Cardiology 69:1009-1014, 1992. 59. Peters RW, Buser GA, Kim HJ, Gold MR. Tricyclic overdose causing sustained monomorphic ventricular tachycardia American Journal of Cardiology 70: 1226-1228, 1992. 60. Peters, RW, Kim HJ, Buser GA, Gold MR. Ischemically-medicated sustained monomorphic ventricular tachycardia. Chest 104:1613-1614, 1993. 61. Peters, RW, Zoble RG, Liebson PR, Powitan Y, Brooks MM, Proschan M; Identification of a secondary peak in myocardial infarction onset 11-12 hours after awakening: The CAST experience J Am Coll Cardiol 22:998-1003,1993. 62. Peters RW, Mitchell LB, Brooks MM, Echt DS, Barker AH, Capone R, Liebson PR,
  16. 16. Greene LH for the CAST Investigators. Circadian Pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial. J AM Coll Cardiol 23:293-289, 1994. 63. Gottlieb SS, Riggio D, Lauria S, Peters, RW, Shorofsky SR, Cines M, Froman D, Gold MR. High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure. J Am Coll Cardiol 23:560-564;1994. 64. Peters, RW, Foster, AH; Shorofsky, SR; Nolan, DA; Gold, MR: Spurions discharges due to late insulation break in endocardial sensing lead for cardiovertor defibrillators, PACE 18:478-481,1995. 65. Peters, RW; Weiss, DN; Carliner, NH; Feliciano, Z Shorofsky, SR; Gold, MR: Overdrive pacing for atrial flutter. American Journal of Cardiology. 1994;74:1021-1023. 66. Riggio DW, Peters, RW, Feliciano Z, Gottlieb SS, Shorofsky SR, Gold MR,. Acute electrophysiologic effects of amiodarone in patients with congestive heart failure. Am J. Cardiol 1995;75:1158-1161. 67. Greenberg HM, Dwyer Jr. EM, Hochman JS, Steinberg JS, Echt DS, Peters RW: Interaction of ischemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. British Heart Journal 1995;74:631-635. 68. Peters RW, Brooks MM, Todd L, Liebson PR, Wilhelmsen L: Smoking cessation and arrhythmic death: the CAST experience. J Am Coll Cardiol 1995;26:1287-1292. 69. Foster MT, Peters RW, Froman D, Shorofsky SR, Gold MR: Electrophysiologic effects and predictors of success of combination therapy with class Ia and Ib antiarrhythmic drugs for sustained ventricular arrhythmias. Am J Cardiol 1996;78:47-50. 70. Tummala RV, Riggio DR, Peters RW, Shorofsky SR, Gold MR: Chronic rise in defibrillation threshold with a hybrid lead system. Am J Cardiol 1996;78:309-312. 71. Peters RW, McQuillan S, Resnick SK, Gold MR: Increased Monday incidence of life-threatening ventricular arrhythmias: experience with a third generation implantable defbrillator. Circulation 1996;94:1346-1349. 72. Goldstein S, Zoble RG, Akiyama T, Cohen JD, Lancaster S, Liebson PR, Rapaport E, Goldberg AD, Peters RW, Gillis AM: The Relationship of Circadian Ventricular Ectopy To Cardiac Mortality. Am J Cardiol 1996;78:881-885. 73. Weiss DN, Gold MR, Peters RW: Rate-responsive pacing mimicking ventricular tachycardia. J Invas Cardiol 1996;8:228-230. 74. Peters RW, Brooks MM, Zoble RG, Liebson PR, Seals AA. Chronobiology of acute myocardial infarction (CAST experience). Am J Cardiol 1996;78:1198-1201.
  17. 17. 75. Kirk MM, Shorofsky SR, Khalighi K, Kavesh NG, Peters RW, Gold MR. Chronic rise of monophasic defibrillation thresholds with a transvenous lead system. Am J Cardiol 1997; 79:502-505. 76. Khalighi K, Florin TJ, Peters RW, Shorofsky SR, Gold MR. Distortion of intracardiac electrograms following defibrillator shocks for atrial tachyarrhythmias. PACE 1997 20:1682-1685. 77. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol 1996; 28:1278-82. 78. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral implantation of cardioverter-defibrillators. PACE 1997; 20:208-211 . 79. Khalighi K, Daly B, Leino EV, Shorofsky SR, Kavesh NG,Peters RW, Gold MR. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol 1997; 79:150-153. 80. Peters RW, Kavesh N, Pelini M, Gold MR. Permanent pacing from the coronary sinus in a patient with an implantable defibrillator PACE 1997; 20:2286-2287. 81. Florin TJ, Weiss DN, Peters RW, Shorofsky SR, Gold MR. Induction of atrial fibrillation with low energy shocks in patients with implantable cardioverter defibrillators. Am J Cardiol 1997; 80:960-962. 82. Khalighi K, Peters RW, Feliciano Z, Shorofsky SR, Gold MR. Comparison of class I and class III antiarrhythmic drugs for the suppression of sustained ventricular tachycardia associated with coronary artery disease. Am J Cardiol 1997; 80:591-594. 83. Gold MR, Olsovsky MR, Pelini MA, Peters RW, Shorofsky SR. Comparison of single- and dual-coil active pectoral defibrillation lead systems. J Am Coll Cardiol 1998; 31:1391-4. 84. Gold MR, Khalighi K, Kavesh NG, Daly B, Peters RW, Shorofsky SR. Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol 1997; 79:1623-1627. 85. Peters RW, Gilbert TB, Johns-Walton S, Gold MR. Lidocaine-related increase in defibrillation threshold. Anesth Analg 1997; 85:299-300. 86. Weiss DN, Shorofsky SR, Peters RW, Gold MR. The effect of delivered energy on defibrillation shock impedance. J Interventional Cardiac Electrophysiol 1998; 2:273-277. 87. Peters RW, Shorofsky SR, Pelini M, Olsovsky M, Gold MR. Overdrive atrial pacing
  18. 18. for conversion of atrial flutter: comparison of postoperative with non-postoperative patients. Am Heart J 1999;137:100-103. 88. Peters RW, Gold MR. Reversible prolonged pacemaker failure due to electrocautery. J Interventional Cardiac Electrophysiol 1998;2:343-344. 89. Peters RW, Cooklin M, Brockman R, Shorofsky SR, Gold MR. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic potentials. J Interventional Cardiac Electrophysiol 1998;2:367-370. 90. Gold MR, Froman D, Kavesh NG, Peters RW, Foster AH, Shorofsky SR. A comparison of pectoral and abdominal transvenous defibrillator implantation: analysis of costs and outcomes. J Interventional Cardiac Electrophysiol 1998;2:345-349. 91. Kavesh NG, Olsovsky MR, Freudenberger RS, Conte JV, Peters RW, Shorofsky SR, Gold MR. Intravenous amiodarone suppression of electrical storm refractory to chronic oral amiodarone PACE 1999;22:665-667. 92. Cooklin M, Tummala RV, Peters RW, Shorofsky SR, Gold MR. Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J 1999;138:133-6. 93. Peters RW, McQuillan S, Gold MR. Interaction of septadian and circadian rhythms in life-threatening ventricular arrhythmias in patients with implantable cardioverter defibrillators. Am J Cardiol 1999;84:555-557. 94. Degeratu FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiol 2000;11:21-24. 95. Gold MR, Brockman R, Peters RW, Olsovsky MR, Shorofsky SR. Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure. Am J Cardiol 2000;85:1106-1109.. 96. Pelini M, Peters RW, Khalighi K, Shorofsky SR, Gold MR. Short term escape rhythm characteristics after radiofrequency ablation of the atrioventricular junction. J Interventional Cardiac Electrophysiol 2000;4:301-305. 97. Ahrensfeld D, Balke CW, Benitez RM, Peters RW. Transient sinus node dysfunction in acute myocardial infarction associated with the use of a coronary stent. Catheterization and Cardiovascular Interventions 2000;50:349-351. 98. Peters RW, Zhang X, Gold MR. Clinical predictors and efficacy of antitachycardia pacing in patients with implantable cardioverter defibrillators: the importance of the patient’s sex. PACE 2001;24:70-74.
  19. 19. 99. Rashba EJ, Olsovsky MR, Shorofsky SR, Kirk MM, Peters RW, Gold MR. Temporal decline in defibrillation thresholds with an active pectoral lead system. J Am Coll Cardiol 2001;38:1150-5. 100. Rashba EJ, Bouhouch R, Koshy S, MacMurdy K, Shorofsky SR, Peters RW, Gold MR. A new algorithm for transthoracic cardioversion of atrial fibrillation based on body weight. Am J Cardiol 2001;88:1043-1045. 101.Peters RW, Zoble RG, Brooks MM. The onset of acute myocardial infarction during sleep. Clin Cardiol 2002;25:237-241. 102. Rashba EJ, Cooklin M, MacMurdy K, Kavesh N, Kirk M, Sarang S, Peters RW, Shorofsky SR, Gold MR. Effects of selective autonomic blockade on T-wave alternans. Circulation 2002;105:837-842. 103. Rashba EJ, Bouhouch R, MacMurdy KA, Shorofsky SR, Peters RW, Gold MR. Effect of shock polarity on the efficacy of transthoracic atrial defibrillation. Am Heart J 2002;143:541-5. 104. Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang s, Peters RW, Shorofsky SR, Gold MR. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 2002;13:845-850. 105. Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 2002;13:770-5. 106. Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Effect of shock polarity on defibrillation thresholds with a hybrid patch-coil lead system. J Interv Card Electrophysiol 2003;9:391-6.. 107. Rashba EJ, Bonner M, Wilson J, Shorofsky SR, Peters RW, Gold MR. Distal right ventricular coil position reduces defibrillation thresholds. J Cardiovasc Electrophysiol 2003;14:1036-40. 108. Shorofsky SR, Peters RW, Rashba EJ, Gold MR: Comparison of step-down and binary-search algorithms for determination of defibrillation threshold in humans. PACE 2004;27:218-20. 109. Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol 2004;15:790-4. 110. Rashba EJ, Gold MR, Crawford FA, Leman RB, Peters RW, Shorofsky SR. A new protocol for transthoracic cardioversion of atrial fibrillation with a biphasic truncated
  20. 20. exponential shock waveform. AM J Cardiol 2004;94:1572-1574. 111. Rashba EJ, Osman AF, Macmurdy K, Kirk MM, Sarang SE, Peters RW, Shorofsky SR, Gold MR. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a propective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol 2004;15:170-76. 112. Rashba EJ, Shorofsky SR, Brown T, Peters RW, Gold MR. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm 2005; 2:49-54. 113. Page RL, Zipes DP, Powell RM, Gold MR, Peters RW, Russo AM, Bigger JT, Sung RJ, McBurnie MA. Seasonal variation in mortality in the Antiarrhythmic drugs versus Implantable defibrillators Study registry. Heart Rhythm 2004;1:435-440. 114. Rashba EJ, Farasat M, Kirk MM, Shorofsky SR, Peters RW, Gold MR. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual coil, transvenous ICD system. J Cardiovasc Electrophysiol 2006;17:617-620. 115. Lederle FA, Sacks JM, Fiore L, Landenfeld CS, Steinberg N, Peters RW, Eid AE, Sebastian J, Stasek JE, Fye CL. The prophylaxis of medical patients for Thromboembolism Pilot Study. Amer J Medicine 2006;119:54-59. 116. Rashba EJ, Shorofsky SR, Scheiner A, Conville R, Peters RW, Ma C, Gold MR. Coronary sinus electrode does not reduce defibrillation thresholds. Heart Rhythm 2006;3:647-652. 117. Khan E, Voudoris A, Shorofsky SR, Peters RW. Inappropriate ICD discharges due to “triple counting” during normal sinus rhythm. Journal Interventional Cardiac Electrophysiology 2006;17:153-155. 118. Dickfeld T, Lei P, Jeudy J, Dong J, Voudouris A, Peters R Saba M, Shekhar R, Shorofsky S. Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography. JACC Imaging 2008 (in Press). ABSTRACTS: 1. Scheinman MM, Kunkle FW, Peters RW, Schoenfeld PL, and Abbott JA: Sinoatrial function and atrial refractoriness in patients with the sick sinus syndrome. Circulation, 48:1973. 2. Peters RW, Paley H, Chamorro G, Mailhot J, and Modin G: Effect of heart rate on Myocardial contractility in man. Circulation 50: (Suppl III) 240, 1974.
  21. 21. 3. Scheinman MM, Brennan M, Peters RW, and Hirschfeld DS: Cooperative prospective study of patients with intraventricular conduction delay (short term results). Circulation, 50 (Suppl III), 1974. 4. Peters RW, Scheinman MM, and Shafton E: Long-term follow-up of patients with radio frequency-triggered atrial pacemakers. Circulation 52: (Suppl III) 2244, 1974. 5. Hirschfeld DS, Peters RW, Kunkle F, and Scheinman MM: Sino-atrial conduction time and abnormal perionodal refractoriness in patients with sinus node disease. Circulation 52:(Suppl II) 231, 1976. 6. Scheinman MM, Brennan M, Modin G, and Peters RW: Cooperative prospective study of bundle branch block. Circulation 52 (Suppl II) 113, 1975. 7. Scheinman MM, Evans GT, Abbott J, Peters RW, Wallace AG, Strauss HC: Electrophysiologic testing of patients with sino-atrial block and sinus pauses. Circulation 53054: (Suppl II) 231, 1976. 8. Peters RW, Scheinman MM, and Rubinstein M: Clinical applications of the intracardiac electrogram. AAMI, Abstract of Proceedings, 1976. 9. Peters RW, Scheinman MM, Hart R, Rubinstein M: Newer techniques in the management of patients with intractable supraventricular tachycardia (SVT). AAMI, Abstracts of Proceedings, 1976. 10. Rubinstein M, Peters RW, O'Young J, Scheinman MM: Instrumentation for intracardiac electrophysiology. AMI, Abstracts of Proceedings, 1976. 11. Massie B, O'Young J, Peters RW, Hirschfeld D, Scheinman MM: Simultaneous sinus slowing and type II atrioventricular block: A manifestation of hypervagotonia. Circulation 55-56: (Suppl III) 154, 1977. 12. Peters RW, Scheinman MM, Modin G, O'Young, Somelifski CA, Mies C: Permanent prophylactic pacing in patients with chronic bundle branch block. American Journal of Cardiology 41:385, 1978. 13. Abbott JA, Feld, O'Young J, Peters RW, Desai J, Scheinman MM, Cheitlin M: Electrocardiographic recognition of acute myocardial infarction. American Federation of Clinical Research, 1978. 14. Abbott JA, Scheinman MM, Sheard C, O'Young J, Desai J, Peters RW, Strauss HC, Modin G: Prognostic indicators of in patients with sinus node dysfunction. American Federation of Clinical Research, 1978. 15. Massie B, O'Young J, Scheinman MM, Strauss H, Peters RW, Desai J: The significance of autonomic blockade in the evaluation of sinus node dysfunction. American Journal of Cardiology 41:433, 1978.
  22. 22. 16. Scheinman MM, Peters RW, et al: Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Cardiology Digest, 1978. 17. Peters RW, McAnulty J, Scheinman M, Murphy E, Somieldfski C, Rahimtoola S: Serial studies of intranatal conduction in patients with bundle branch block. Circulation 58: (Suppl II) 606, 1978. 18. Desai J, Hirscfeld D, Peters RW, Scheinman M, Gonzalez R: Electromechanical dissociation associated with disopyramide. Circulation 58: (Suppl II) 190, 1978. 19. Massie B, O'Young J, Scheinman M, Strauss H, Desai J, Peters RW: Pharmacologic challenge in the testing of patients with sinus node dysfunction. Clin Res 26(2):251A 20. Peters RW, Scheinman M, Dhingra R, Rosen K, McAnulty J, Rahimtoola S: Site and pattern of progressive atrioventricular block in patients with bundle branch block: A long-term collaboration study. Circulation 60: (suppl II) 190, 1979. 21. Scheinman M, Desai J, Gonzalez R, Peters RW, Thomas A, Dzindzio B: The effects of Lidocaine on His bundle automaticity and rhythm in man. Circulation 58: (Suppl II) 29, 1978. 22. Fisher ML, Collins D, Kelemen M, Morris F, Carliner NH, Peters RW, Moran G, Plotnick GD: Serum enzymes in diagnosis of acute myocardial infarction: Cost effectiveness. American Federation of Clinical Research 28:294A, 1980. 23. Plotnick GD, Peters RW, Fisher ML: Arrhythmias in "Variant Angina". Clinical Research 28:202A, 1980. 24. Peters RW, Abbott J, Desai J, Frais M, Scheinman M: Natural history of bundle branch block effects of prophylactic pacemaker insertion. Proceedings of European Congress of Cardiology. Paris, France, June 22-26, 1980. 25. Somelofski CA, Peters RW: Role of a nurse clinical trial. Proceedings of European Congress of Cardiology. Paris, France, June 22-26, 1990. 26. Resnick S, Peters RW, Fisher ML, Plotnick GD, Carliner NH, Moran G: Effect of changes in left ventricular volume upon infranodal conduction in man. Clinical Research 28:617A, 1980. 27. Peters RW, et al: Prophylactic permanent pacemakers for patients with chronic bundle block. Medilex Digest Cardiology. August, 1980, pages 69-70. 28. Hanlon I, Scheinman MM, Desai J, Hess D, Gonzalez R, Peters RW, Budge R: Mechanisms of ventricular tachycardia termination by vagal maneuvers. Proceedings of European Congress of Cardiology. Paris, France, June 22-26, 1980.
  23. 23. 29. Plotnick GD, Learner B, Carliner NH, Fisher ML, Peters RW, Becker L: Are collaterals uncommon in patients with unstable angina? Clinical Research 28:202A, 980. 30. Fisher ML, Collins D, Kelemen M, Morris F, Carliner NH, Peters RW, Moran G, Plotnick GD, Serum enzymes in diagnosis of acute myocardial infarction: Cost effectiveness. Clinical Research 28:294A, 1980. 31. Wohl B, Peters RW, Fisher ML, Carliner NH, Plotnick GD: Late unheralded pacemaker pocket infections due to staphylococcus epidermidas: A clinical entity. Clinical Research 29:661A, 1981. 32. Fisher ML, Plotnick GD, Hamilton BP, Peters RW, Carliner NH, Mersey JH: Intrinsic symptomimetic activity of pindolol: Evidence for interaction with pretreatment symptomimetic tone. Clinical Research 9:650A, 1981. 33. Peters RW, Scheinman MM, Dhingra R, Rosen K, McAnulty J, Rahimtoola S: Serial electrophysiologic studies in patients with bundle branch block. Circulation 64: (Suppl IV) 144, 1981. 34. Scheinman MM, Peters RW, Sauve MJ, Desai J, Cogan J, Wohl B: Graded influence of the H-V interval on the incidence of spontaneous infranodal block. Circulation 64: (Suppl IV) 144, 1981. 35. Scheinman MM, Peters RW, Sauve MJ, Desai J, Abbott J: Prognosis of patients with bundle branch block: Role of prophylactic pacing. International symposium on Cardiology Electrophysiology, page 55, Ferrara, April-May, 1981. 36. Peters RW, Fisher ML, Resnick S, Plotnick GD, Carliner NH, Scheinman MM: Effects of acute changes in ventricular volume and pressure on A-V conduction. American Journal of Cardiology, 49:982, 1982. 37. Fisher ML, Plotnick GD, Hamilton JH, Hamilton BP, Peters RW, Carliner NH, Mersey JH: Intrinsic sympathomimetic activity of pindolol: Evidence for interaction with pretreatment sympathetic tone. American Journal of Cardiology, 49:924, 1982. 38. Peters RW, Scheinman MM, Sauve MJ, Desai J, Williams K, Cogan J, Wohl B: Permanent prophylactic cardiac pacing for patients with bundle branch block. American Journal of Cardiology, 49:952, 1982. 39. Higgins J, Scheinman M, Morady F, Hess D, Peters RW: Electrophysiologic evaluation of patients with bundle branch block and syncope. Circulation 66: (Suppl II) 147, 1982. 40. Peters RW, Hamilton BP, Hamilton JH, Levinson PD, Kuzbida G, Pavlis R: The incidence of arrhythmias following abrupt clonidine withdrawal. Clinical Research 30:693A, 1982.
  24. 24. 41. Moran GW, Carliner NH, Fisher ML, Rapport A, Kelemen M, Peters RW, Gadacz T, Plotnick GD: Should exercise testing be performed routinely before major noncardiac surgery? Clinical Research 30L676A, 1982. 42. Magiros E, Kushner M, Peters RW, Carliner NH, Fisher ML, Plotnick GD: Electrophysiology of oral cibenzoline. Clinical Research 30:693A, 1982 43. Peters RW, Valenti S, Benowitz N, Plotnick GD, Carliner NH, Charache S, Fisher ML, Plotnick GD: Electrophysiologic Effects of Cigarette Smoking in Man. Circulation 68: (Suppl III) 421, 1983. 44. Davis RJ, MacLaren D, Peters RW: Possible interaction between cortisporin otic suspension and warfarin. Annals of the American Society of Hospital Pharmacists, 1983. 45. Peters RW, Scheinman MM, Morady F, Jacobson L: Long-term management of paroxysmal tachycardia by burst overdrive pacing. Journal of the American College of Cardiology, 3 (2):473, 1984. 46. Carliner NH, Fisher ML, Rapport A, Kelemen M, Moran G, Peters RW, Gadacz T, Plotnick GD: Preoperative exercise testing: Stratification of risk for major non-cardiac surgery. Journal of the American College of Cardiology 1 (2):638, 1983. 47. Whipps RG, Carliner NH, Peters RW, Plotnick GD, Lesko L, Fisher ML: Nifedipine: Time course of serum concentrations and hemodynamic changes during chronic oral therapy. Clinical Research 32:248A, 1984. 48. Peters RW: Barker A, Byington R: Prognostic value of QTc prolongation: The BHAT experience. Circulation 70:6, 1984. 49. Peters RW: Permanent cardiac pacing for complete heart block complicating acute anterior myocardial infarctions. Cardiostimolazione 2:196, 1984. 50. Kostis JB, Byington RP, Goldstein S, Peters RW, Murphy ML: Mortality predictors in survivors of myocardial infarction. The BHAT placebo group. JACC 1986. 51. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM: Propranolol and the circadian variation in frequency of sudden cardiac death. Circulation 76: (Supp IV) 364, 1987. 52. Benowitz NL, Peters RW: Modin G: Benefit of propranolol in the Beta Blocker Heart Attack trial is primarily in cigarette smokers. Clinical Pharmacal Ther 43:162, 1988. 53. Peters RW, Mitchell LB, Pawitan Y, Barker AH, Capone RJ, Echt DS: Circadian pattern of Sudden Arrhythmic death in patients receiving encainide or flecainide in the Cardiac Arrhythmia Suppression Trial. Circulation 82:546 1990.
  25. 25. 54. Gillis AM, Peters RW: Mitchell LB, Duff HJ, McDonald M. Wyse DG: Circadian Variation of Ventricular Arrhythmias: role of left ventricular function. JACC 17:222A, 1991. 55. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene L, Huther M, Richardson D. JACC 17:17A, 1991. 56. Peters RW, Carliner NH: Overdrive atrial pacing for atrial flutter. PACE 14:683, 1991. 57. Peters RW, Zoble RG, Pawitan Y, Liebson P, Ettinger A: Relationship of onset of myocardial infarction to the time of awakening. Circulation 84: (Suppl II) 244, 1991. 58. Greenberg HM, Hochman JS, Steinberg JS, Mitchell LB, Echt DS, Peters RW, Baker AH, Greene HL, Dwyer E M Jr for the CAST Investigators. Interaction of ischemia and encainide/flecainide treatment: A proposed mechanism for the increased mortality in CAST I. Circulation 86:315, 1992. 59. Peters RW, Zoble RG, Brooks MM, Liebson PR, Barker A, Seals, MA for the CAST Investigators: Increased onset of acute myocardial infarction on Monday. Circulation, 88:I-509, 1993. 60. Peters RW, Todd L, Brooks MM, Liebson PR, Wilhelmsen L for the CAST Investigators. Smoking Cessation and Arrhythmic death: The CAST experience Circulation . 88:I-556, 1993. 61. Riggio DW, Peters, RW, Gottlieb SS, Gold MR. Electrophysiologic effects of high dose oral amiodarone load in heart failure patients. JACC 23:134A, 1994. 62. Foster M, Shorofsky SR, Peters RW, Gold MR. Combination therapy with type 1 antiarrhythmic drugs: electrophysiologic predictions of efficacy JACC 23:36A, 1994. 63. Gottlieb SS, Lauria S, Riggo DW. Peters RW, Shorofsky SR, Cines M, Froman D, Gold MR. High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure JACC 23:484A, 1994. 64. Florin, TJ; Weiss, DN; Feliciano, Z; Tummala, RV; Shorofsky, SR, Peters, RW, Gold MR. Induction of atrial fibrillation with low energy shocks. Circulation . 1994;90:40I-541. 65. Weiss, DN, Tummala R V, Feliciano Z, Peters, RW, Shorofsky SR, Froman, DM; Gold, MR: A comparison of d-sotalol and d,l sotatol for treatment of ventricular tachycardia circulation . Circulation 1994;90:40I-544
  26. 26. 66. Peters, RW, McQuillan S, Kaye SA, Gold MR Increased Monday incidence of life threatening Ventricular Arrhythmias: experience with a third generation implantable defibrillator. JACC 1995;25:188A 67. Greene L, Peters R, McBride R, McAnulty J. Effects of intraventricular conduction delay on survival in patients taking antiarrhythmic drugs. JACC 1995;25:19A. 68. Florin TJ, Weiss DN, Feliciano Z, Khalighi K, Schneider A, Shorofsky SR, Peters RW, Gold MR. The induction of atrial fibrillation with low energy defibrillator shocks is related to lead and pulse width. Circulation 1995;92:I-141. 69. Gold MR, Peters RW, Johnson J, Shorofsky SR. Complications associated with subcutaneous and submuscular pectoral cardioverter defibrillator placement. PACE 1996;19:575. 70. Gold MR, Kavesh NG, Peters RW, Shorofsky SR. Biphasic waveforms prevent the chronic rise of transvenous defibrillation thresholds. Circulation 1996;94:I-321. 71. Gold MR, Zhang X, Palmer G, Peters RW, Kavesh NG, Shorofsky SR. Clinical predictors and efficacy of antitachycardia pacing therapy for the treatment of ventricular tachycardia. PACE 1997;20:1567. 72. Degeratu FT, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in implantable defibrillators J Am Coll Cardiol 1999;30:142A. 73. Page RL, Luceri RM, Gold MR, Peters RW, Follman DA, Russo AM, Powell JL, Bigger JT, Kim CH, Sung RJ, Zipes DP, Yao Q, Lancaster S. Patterns of mortality in the Antiarrhythmics versus Implantable Defibrillators (AVID) study registry: evidence for increased mortality related to the winter holidays. PACE 1999;22:712. 74. Gold MR, Rottman JN, Wood MA, Lehmann MH, Batsford WP, Peters RW, Hafley G, Buxton AE. The effect of clinical factors on the benefit of implantable defibrillators in the MUSTT Trial. Circulation 1999;100:642. . 75, Peters RW, Gold MR, Carlson MD, Zipes DP, Follman D, Sheldon RS, Mounsey P, Lancaster S and the AVID Investigators. Seasonal variation in implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;35:150A. 76. Gold MR, Daubert JP, Peters RW, Shorofsky SR. A clinical trial of a combined atrial and ventricular defibrillator in patients without ventricular arrhythmias. J Am Coll Cardiol 2000;35:115A. 77. Rashba EJ, Olsovsky MR, Shorofsky SR, Kirk M, Peters RW, Gold MR. Defibrillation thresholds improve significantly over time with an active pectoral lead system. PACE 2000;23:631.
  27. 27. 78. Kirby SR, Degeratu FT, Rashba EJ, Shorofsky SR, Peters RW, Gold MR. The efficacy of multimodal therapy with pacing, cardioversion and amiodarone to maintain sinus rhythm in patients with “chronic” atrial fibrillation and congestive heart failure. J Am Coll Cardiol 2001;37:93A. 79. Rashba EJ, Macmurdy K, Cooklin M, Kirk M, Peters RW, Shorofsky SR, Gold MR. Sympathetic blockade markedly reduces T wave alternans. Circulation 2001;104:II-690 80. Rashba EJ, Shorofsky SR, Peters RW, DeGroot PJ, Havel WJ, Gold MR. Low capacitance shocks decrease the safety margin for transvenous ventricular defibrillation. PACE 2002;25, 554. 81. Rashba EJ, Shorofsky SR, MacMurdy K, Peters RW, Sarang S, Gold MR. Prognostic significance of indeterminate T wave alternans results. PACE 2002;25:564. 82. Rashba EJ, Shorofsky SR, MacMurdy K, Sarang S, Peters RW, Gold MR. Influence of left ventricular function on the prognostic value of t wave alternans. PACE 2002;25:605. 83. Kirby DS, Shorofsky SR, Rashba EJ, Peters RW, Gold MR. The efficacy of multimodal therapy for maintenance of sinus rhythm in patient swith “chronic” atrial fibrillation and congestive heart failure. PACE 2002;25:600. 84. Koul A, Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Is 360 joules necessary for biphasic transthoracic cardioversion of atrial fibrillation? PACE 2002;25:688. 85. Rashba EJ, Peters RW, Shorofsky SR, Gold MR. Enhanced detection of arrhythmia vulnerability using T wave alternans and programmed ventricular stimulation. PACE 2002;25:563. 86. Dickfeld T, Lodge M, Voudoris A, Khan E, Ma C, Sayed S, Lee JH, Peters R, Dilsizian V, Shorofsky S. Anatomic-metabolic scar imaging with positron emission tomography for guidance of ventricular tachycardia ablations. Heart Rhythm Society, 2006.
  28. 28. BOOKS AND CHAPTERS: 1. Scheinman MM, Peters RW: Clinical and electropharmacologic characteristics of patients with bundle branch block. In Cardiac Pacing. Edited by N. El - Sherif and P. Samet. Grune and Stratton, New York, 1980. 2. Goldschlager N, Scheinman MM, and Peters RW: Atrioventricular intraventricular block in patients with acute myocardial infarction. In Coronary Care. Edited by Karliner JS and Gregoratos G. Churchill Livingston, New York, 1981, Chapter 18, pp 425-448. 3. Scheinman MM, Peters RW, Sauve MJ, Desai JM, Abbott JA: Clinical Significance of HV interval in patients with chronic bundle branch block and the role of permanent pacemaker insertion. In: Cardiac Electrophysiology Today, Academic Press, 1982. 4. Peters RW, Scheinman MM, Sauve MJ, Williams K, Desai J, Abbott J, Cogan J: Bundle branch block: Anatomic electrophysiologic and clinical correlates. In Cardiology Update. (Ed. E. Rapport), Elsevier, North Holland New York, 1983 pp 219-240. 5. Morady F, Peters RW, Scheinman MM: Bradyarrhythmias and bundle branch block. In Medical Emergencies (Ed. M. Scheinman), Saunders, Philadelphia, 1984, Chapter 7, pp 135-151. 6. Peters RW, Scheinman MM: Anatomic and electrophysiologic aspects of fascicular block. In Cardiac Arrhythmias: From Diagnosis to Therapy. (Ed M. Scheinman and Samuel Levy), Futura, Mt. Kisco, New York, 1984, Chapter 7, pp 137-165. 7. Peters RW, Scheinman MM: Bundle branch block and atrioventricular conduction disturbances. In Cardiology (Eds Parmley WW, Chatterjee K. JB Lippincott Company, Philadelphia , 1988. Volume 1, Chapter 68 pp 1-22. 8. Peters RW, Scheinman MM: Bundle branch block and atrioventricular conduction disturbances. In Cardiology: An Illustrated Text/Reference. (Eds. W.W. Parmley, Chatterjee) JB Lippincott Company, Kansas City, 1991. Volume 1, Chapter 48 pp 111-127. 9. Peters RW: Pacemaker techniques for managements of supraventricular tachycardia in Cardiac Preexcitation Syndromes: Origins, evaluation and treatment. (Ed. D.C. Benditt, D.W. Benson, Jr.) Kluwer Academic Publishers, Norwell, Massachusetts, 1986, Chapter 23, pp 481-490. 10. Peters RW: Heart Block in acute Myocardial Infarction. In Modern Coronary Care, (Ed G. Francis and J. Alpert) Little, Brown and Company, Boston, 1995, Chapter 10, pp 177-192.
  29. 29. 11. Peters RW: Effect of Beta-Blockers on Circadian Variation of Sudden Cardiac Death In Survivors of Myocardial Infarction. In Beta-Blockers and Cardiac Arrhythmic (Ed. P. Deedwania) Marcel Dekker, Inc., N.Y. 1992, Chapter 7, pp 151-164. 12. Ellenbogen KA, Peters RW: Indications for permanent and temporary cardiac pacing In Principles of Cardiac Pacing (Ed K. Ellenbogen) Blackwell Scientific Publications, Cambridge, MA 1996, 2nd Edition, Chapter 1, pp 1-36. 13. Gold MR, Peters RW: Tachycardias In Conn's Current Therapy (Ed R.E Rakel) WB Saunders Company, Philadelphia, 1995 pp 236-241. 14. Peters, RW: Circadian rhythm of sudden cardiac death. In: Circadian Rhythms of Cardiovascular Disorders (Ed P. Deedwania) Futura Publishing Company, Armonk, N.Y. 1997, Chapter 8, pp147-162. 15. Gold MR, Peters, RW: Pacing in heart failure. In: Clinical Cardiac Pacing (Ed K Ellenbogen, G Neal Kay, B Wilkoff) WB Saunders Company, Philadelphia, 2000, Chapter 20, pp 497-507. 16. Peters RW, Gold MR. Bradyarrhythmias and indications for pacing – new and emerging. In: Management of Cardiac Arrhythmias (Ed L Ganz) Humana Press, Totowa, New Jersey 2002, Chapter 11, pp163-182. 17. Peters RW, Ellenbogen KA. Indications for permanent and temporary cardiac pacing. In: Cardiac Pacing 3rd Edition (Ed K Ellenbogen) Blackwell Scientific Publications, Cambridge, MA, 2001, Chapter 1 pp 1-47. 18. Gold MR, Peters RW. How great is the arrhythmic risk for heart failure patients and does resynchronization therapy modify it. In: Cardiac Arrhythmias 2001 (Ed A Raviele), Springer, Milan, Italy 2001, pp 151-156. 19. Peters RW, Gold MR. Permanent pacemakers and antiarrhythmic devices. In: Irwin and Rippe’s Intensive Care Medicine, 5th Edition, Silverchair Science & Communications, Charlottesville, VA. (In Press). 20. Gold MR, Peters RW. Newer applications of pacemakers. In: Cardiac Electrophysiology: From Cell to Bedside. 4th Edition (Ed Zipes DP) W B Saunders, Philadelphia. 2004, Chapter 110, pp1011-1017. 21. Peters RW, Gold MR. Heart Block. In: Conn’s Current Therapy 2005 (Eds Rakel RE, Bopes ET) Elsevier Saunders 2005, pp 349-353. 22. Pugazhendhi P, Peters RW, Ellenbogen KA. Indications for permanent and temporary cardiac pacing. In: Cardiac Pacing, 4th edition (Ed K Ellenbogen), Blackwell Scientific Publications, Cambridge, MA 2005, chapter 1, pp 1-46.
  30. 30. 23. Peters RW, Pugazhendhi, P, Ellenbogen KA. Indications for permanent and temporary cardiac pacing. In Cardiac Pacing 5th edition (Ed K Ellenbogen), Blackwell Scientific Publications, Cambridge, MA 2008, (In Press). 24. Peters RW, Gold MR. Newer applications of pacemakers. In: Cardiac Electrophysiology: From Cell to Bedside. 5th Edition (Ed Zipes DP) WB Saunders, Philadelphia (in Press). EDUCATIONAL MATERIALS: 1. Audiovisual Tape Cassette Series on Acute Myocardial Infarction (National Library of Medicine). Produced with funds granted from the National Medical Audiovisual Library, Maryland 21201 a. Margaretten W. and Scheinman MM: Anatomy and pathology of acute myocardial infarction. b. Parmley W: Pathophysiology of acute myocardial infarction. c. Peters RW and Goldman H: Diagnosis of acute myocardial infarction. d. Scheinman MM: Arrhythmias in myocardial infarction. e. Parmley W: Pump failure in myocardial infarction.

×